Quarterly report pursuant to Section 13 or 15(d)

Supplemental Financial Statement Information - Components of Other Income (Details)

v3.23.3
Supplemental Financial Statement Information - Components of Other Income (Details) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 01, 2023
Jun. 26, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Debt Instrument [Line Items]              
Interest Expense     $ (672,000) $ (740,000) $ (2,777,000) $ (1,184,000)  
Warrant Incentive Expense     0 0 (16,174,000) 0  
Gain on Revaluation of Warrants     2,797,000 166,000 8,999,000 434,000  
Gain (Loss) on Revaluation of Equity Investment in YFE     (2,325,000) (4,071,000) 1,102,000 (1,170,000)  
Realized Loss on Marketable Securities Investments     (1,897,000) (36,000) (4,154,000) (160,000)  
Loss on Foreign Exchange     (637,000) (1,336,000) (282,000) (2,596,000)  
Interest Income     95,000 257,000 563,000 759,000  
Loss on Early Lease Termination     (232,000) 0 (232,000) 0  
Finance Lease Interest Expense     (47,871) (42,000) (152,000) (72,000)  
Other Nonoperating Income (Expense)     11,000 0 37,000 0  
Other Expense, net     (2,236,000) (5,062,000) (10,293,000) (2,805,000)  
Investment income, interest     100,000   400,000    
Lyndhurst, NJ              
Debt Instrument [Line Items]              
Loss on Early Lease Termination     (200,000)        
Loss on early lease termination $ 100,000            
Termination of lease, fees $ 100,000            
Warrant              
Debt Instrument [Line Items]              
Warrants and rights outstanding     36,500,000   36,500,000   $ 73,300,000
Warrant | Exchange Warrants              
Debt Instrument [Line Items]              
Warrants and rights outstanding   $ 12,700,000 12,700,000   12,700,000    
Warrant | 2021 Warrants              
Debt Instrument [Line Items]              
Incremental warrant incentive expense   3,500,000 3,500,000        
Warrant | Warrants              
Debt Instrument [Line Items]              
Gain on Revaluation of Warrants     2,700,000   8,800,000    
Warrants and rights outstanding   $ 13,100,000 4,300,000   4,300,000    
Margin Loan              
Debt Instrument [Line Items]              
Interest expense, debt     200,000 $ 400,000 1,500,000 $ 600,000  
Production Facilities Loans and Bank Indebtedness              
Debt Instrument [Line Items]              
Interest expense, debt     $ 500,000   $ 1,300,000